MiscellaneousLumbar discectomy and the diabetic patient: incidence and outcome
References (18)
- et al.
An H S. The results of operations on the lumbar spine in patients who have diabetes mellitus
J Bone Joint Surg Am
(1993) - et al.
Patient selection for lumbar discectomy. An objective approach
Spine
(1979) - et al.
Seven-year clinical follow-up after lumbar disc surgery; results and predictors of outcome
BJ of Neurosurgery
(1999) - et al.
Quality of life assesment in clinical trials
- Ryan, B, F, Joiner, B, L, Ryan, T, A, 1985, 186,...
- Pearson, J C G, Turton, A, Statistical methods in environmental health, London, Chapman and Hall, 1993, 93,...
- Circular on Epidemiology by ACT Department of Health. Diabetes Australia, July...
- et al.
Lumbar spinal stenosis and diabetes. Outcome of surgical decompression
J Bone Joint Surg Br
(1994) - et al.
Surgical outcome of 438 patients treated surgically for lumbar spinal stenosis
Spine
(1997)
Cited by (85)
Perioperative Management of Comorbidities in Spine Surgery
2023, Orthopedic Clinics of North AmericaIndications
2021, Revision Lumbar Spine SurgeryDural Scarring and Repair Issues
2021, Revision Lumbar Spine SurgeryDisc Herniation (Primary, Recurrent, Residual)
2021, Revision Lumbar Spine SurgeryHyperglycemia and its influence on development of lumbar degenerative disc disease
2020, North American Spine Society JournalCitation Excerpt :Therefore, diabetes can be considered a risk factor for spinal stenosis, although the mechanism of the risk for spinal stenosis in patients with diabetes is not well defined.[7,8]. Approximately 13% of patients who undergo lumbar disc surgery were diagnosed with diabetes, whereas the prevalence of diabetes in the same population generally was approximately 8% [9]. Diabetic microangiopathy might affect the nutrition of the spine and lead to disc degeneration [10].
The role of estrogen in intervertebral disc degeneration
2020, SteroidsCitation Excerpt :However, how estrogen exerts anti-inflammatory effects to protect the IVD in vivo and its specific mechanisms have not been reported so far. Some interdisciplinary clinical studies proved that diabetes mellitus is a predisposing factor of IVDD [144,145]. Recently, several in vitro studies showed that high-glucose cultured NP cells adversely affects the biology of NP cells through oxidative damage, such as reducing cell viability and promoting matrix degradation [146–148].
- f1
Correspondence to: R. L. Newcombe, Director, Neurosurgical Unit, Canberra Clinical School of The University of Sydney, The Canberra Hospital, Woden ACT, 2605 Australia.